To hear about similar clinical trials, please enter your email below
Trial Title:
FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients
NCT ID:
NCT06282562
Condition:
Brain Tumor, Primary
Exercise
Conditions: Official terms:
Brain Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Single (Participant)
Intervention:
Intervention type:
Other
Intervention name:
High-Intensity Interval Training (HIIT)
Description:
Individualized High-Intensity Interval Training (HIIT) program with two exercise sessions
per week for 12 weeks. The exercise sessions will be conducted on a stationary bike, with
intensity tailored to each participant's maximum exercise capacity.
Arm group label:
HIIT
Summary:
The FeelFit study aims to assess the effectiveness of High-Intensity Interval Training
(HIIT) in improving self-reported physical fitness in adult brain tumor patients during
periods of stable disease, as compared to a waiting-list control group. Furthermore,
several secondary and exploratory outcomes will be evaluated. The study is part of the
GRIP (GuaRding quality survivorshiP) project, which aims to improve quality of life in
brain tumor patients.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- reduced self-reported physical fitness;
- minimum age of 18 years;
- diagnosed with a primary brain tumor;
- stable disease, i.e. no signs of radiological or clinical tumor progression;
- no oncological treatment for at least two months prior to inclusion;
- able to speak, read and write in Dutch.
Exclusion Criteria:
- Karnofsky Performance Score < 70;
- already participated in a HIIT program < 1 month prior;
- contraindication of exercise.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
VU University Medical Centers, location VUmc
Address:
City:
Amsterdam
Zip:
1081 HV
Country:
Netherlands
Status:
Recruiting
Contact:
Last name:
Marieke Blom, Msc
Phone:
+31621522442
Email:
gripopfitheid@amsterdamumc.nl
Start date:
March 2024
Completion date:
August 15, 2026
Lead sponsor:
Agency:
Amsterdam UMC, location VUmc
Agency class:
Other
Source:
Amsterdam UMC, location VUmc
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06282562
